383 related articles for article (PubMed ID: 24638989)
1. Vildagliptin: a review of its use in type 2 diabetes mellitus.
Keating GM
Drugs; 2014 Apr; 74(5):587-610. PubMed ID: 24638989
[TBL] [Abstract][Full Text] [Related]
2. Vildagliptin: a review of its use in type 2 diabetes mellitus.
Keating GM
Drugs; 2010 Nov; 70(16):2089-112. PubMed ID: 20964454
[TBL] [Abstract][Full Text] [Related]
3. Vildagliptin: a review of its use in the management of type 2 diabetes mellitus.
Croxtall JD; Keam SJ
Drugs; 2008; 68(16):2387-409. PubMed ID: 18973400
[TBL] [Abstract][Full Text] [Related]
4. [Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes].
Scheen AJ; Paquot N
Rev Med Liege; 2009 Mar; 64(3):161-7. PubMed ID: 19418936
[TBL] [Abstract][Full Text] [Related]
5. Update: vildagliptin for the treatment of Type 2 diabetes.
Garber AJ; Sharma MD
Expert Opin Investig Drugs; 2008 Jan; 17(1):105-13. PubMed ID: 18095923
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea.
Lukashevich V; Del Prato S; Araga M; Kothny W
Diabetes Obes Metab; 2014 May; 16(5):403-9. PubMed ID: 24199686
[TBL] [Abstract][Full Text] [Related]
8. Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
Rosenstock J; Fitchet M
Int J Clin Pract Suppl; 2008 Mar; (159):15-23. PubMed ID: 18269437
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet.
Halimi S; Schweizer A; Minic B; Foley J; Dejager S
Vasc Health Risk Manag; 2008; 4(3):481-92. PubMed ID: 18827867
[TBL] [Abstract][Full Text] [Related]
10. Translating science into clinical practice: focus on vildagliptin in combination with metformin.
Barnett AH
Diabetes Obes Metab; 2009 May; 11 Suppl 2():18-26. PubMed ID: 19385980
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus.
Pan C; Xing X; Han P; Zheng S; Ma J; Liu J; Lv X; Lu J; Bader G;
Diabetes Obes Metab; 2012 Aug; 14(8):737-44. PubMed ID: 22369287
[TBL] [Abstract][Full Text] [Related]
12. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
[TBL] [Abstract][Full Text] [Related]
13. A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study.
Filozof C; Gautier JF
Diabet Med; 2010 Mar; 27(3):318-26. PubMed ID: 20536495
[TBL] [Abstract][Full Text] [Related]
14. Drug evaluation: vildagliptin-metformin single-tablet combination.
Tahrani AA; Piya MK; Barnett AH
Adv Ther; 2009 Feb; 26(2):138-54. PubMed ID: 19288260
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting.
Melzer Cohen C; Davis C; Shalev V; Chodick G
J Diabetes; 2018 Jan; 10(1):68-72. PubMed ID: 28418203
[TBL] [Abstract][Full Text] [Related]
16. Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients.
Cakirca M; Karatoprak C; Zorlu M; Kiskac M; Kanat M; Cikrikcioglu MA; Soysal P; Hursitoglu M; Camli AA; Erkoc R; Abdul-Ghani M
Drug Des Devel Ther; 2014; 8():239-43. PubMed ID: 24627624
[TBL] [Abstract][Full Text] [Related]
17. Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus.
Bosi E; Dotta F; Jia Y; Goodman M
Diabetes Obes Metab; 2009 May; 11(5):506-15. PubMed ID: 19320662
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
Schweizer A; Dejager S; Bosi E
Diabetes Obes Metab; 2009 Aug; 11(8):804-12. PubMed ID: 19476473
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION).
Ji LN; Pan CY; Lu JM; Li H; Zhu DL; Li Q; Li QF; Peng YD; Tian HM; Yao C; Zhao ZG; Wang L; Wang BH;
Diabetes Obes Metab; 2016 Aug; 18(8):775-82. PubMed ID: 27406394
[TBL] [Abstract][Full Text] [Related]
20. Vildagliptin and vildagliptin/metformin: new drug. Same limited efficacy as sitagliptin in type 2 diabetes.
Prescrire Int; 2008 Oct; 17(97):188. PubMed ID: 19534040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
